Revolution Medicines, Inc. is 6.4x more valuable than CRISPR Therapeutics AG by market capitalization ($30.74 B vs $4.77 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRSP | RVMD |
|---|---|---|
| Market cap | $4.77 B | $30.74 B |
| US-listed rank | #1422 | #453 |
| Revenue (latest FY) | $3.51M | $0.00 |
| Net income (latest FY) | -$581.60M | -$1.13B |
| Net margin | -16569.8% | - |
| SEC filings | 837 | 782 |
Revolution Medicines, Inc. is 6.4x more valuable than CRISPR Therapeutics AG by market capitalization ($30.74 B vs $4.77 B).
In their latest fiscal years, CRISPR Therapeutics AG reported $3.51M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: CRISPR Therapeutics AG and Revolution Medicines, Inc., or browse the full rankings.